Handelsbanken Fonder AB Sells 600 Shares of Teleflex Incorporated (NYSE:TFX)

Handelsbanken Fonder AB lessened its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 4.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 13,300 shares of the medical technology company’s stock after selling 600 shares during the quarter. Handelsbanken Fonder AB’s holdings in Teleflex were worth $2,367,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Avior Wealth Management LLC grew its holdings in Teleflex by 190.6% during the 3rd quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock valued at $38,000 after buying an additional 101 shares in the last quarter. Ashton Thomas Securities LLC purchased a new position in Teleflex during the 3rd quarter valued at approximately $40,000. True Wealth Design LLC grew its holdings in Teleflex by 16,600.0% during the 3rd quarter. True Wealth Design LLC now owns 167 shares of the medical technology company’s stock valued at $41,000 after buying an additional 166 shares in the last quarter. Capital Performance Advisors LLP purchased a new position in Teleflex during the 3rd quarter valued at approximately $54,000. Finally, Banque Cantonale Vaudoise grew its holdings in Teleflex by 184.8% during the 3rd quarter. Banque Cantonale Vaudoise now owns 225 shares of the medical technology company’s stock valued at $56,000 after buying an additional 146 shares in the last quarter. Institutional investors own 95.62% of the company’s stock.

Teleflex Price Performance

Shares of Teleflex stock opened at $177.45 on Tuesday. The stock has a market cap of $8.24 billion, a price-to-earnings ratio of 35.28, a price-to-earnings-growth ratio of 1.73 and a beta of 1.16. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The stock has a 50 day moving average price of $176.98 and a 200-day moving average price of $207.11. Teleflex Incorporated has a one year low of $165.62 and a one year high of $249.90.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on the company. Truist Financial cut their price target on Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a report on Wednesday, December 18th. Royal Bank of Canada cut their price target on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a report on Friday, November 1st. StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, November 28th. Mizuho dropped their target price on Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a report on Friday, November 1st. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a report on Monday, December 16th. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $246.00.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.